* Uplistings will reprice cannabis stocks higher and likely lead the way to institutional ownership * I am growing more bullish on the cannabis space — having repurchased $MSOS on Wednesday * MSOS and Trulieve’s shares moved higher yesterday on moves aimed by $TCNNF to facilitate NYSE uplisting * Expect other MSOS to uplist in …
Read in context ›AdvisorShares Pure US Cannabis ETF (MSOS)
Track AdvisorShares Pure US Cannabis ETF through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
Read the latest TheStreet Pro articles mentioning AdvisorShares Pure US Cannabis ETF, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
29 articlesDaily Diary Mentions
241 mentionsLet’s Get Chai (Again!) Doesn’t Make Sense I don’t think today’s decline in cannabis stocks makes much sense. I have gotten aggressive with $MSOS on a scale lower. My average cost is about $4.76 Position: Long MSOS (M)
Read in context ›Bought a Hunk of MSOS I bought a hunk of $MSOS at $4.82. Position: Long MSOS (S)
Read in context ›Why We've Eliminated Nearly All Our Cannabis Holdings on This Week's Strength * Reading the fine print of the rescheduling announcement should give cannabis investors some pause over the near term (the 280E tax payment clock is still ticking!) * Industry promotional discounting continues — same-store sales are still weak, store bases are overbuilt and new unit ...
Read in context ›Things I Did Today Here are today's things: * Shorted SPY at $709.28 and QQQ at $650.96 * Sold out of my MSOS at $5.13. * Eliminated the following individual cannabis equities: CURLF at $3.98, GLASF at $9.98, GTBIF at $8.51, TCNNF at $8.61, VRNO at ...
Read in context ›
